Related references
Note: Only part of the references are listed.Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy
Weiming Liu et al.
ACTA DIABETOLOGICA (2021)
Fostering next-generation probiotics in human gut by targeted dietary modulation: An emerging perspective
Manorama Kumari et al.
FOOD RESEARCH INTERNATIONAL (2021)
Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy
Taraprasad Das et al.
SCIENTIFIC REPORTS (2021)
The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
Chae Bin Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
Yinhua Huang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Problems with the concept of gut microbiota dysbiosis
Harald Brussow
MICROBIAL BIOTECHNOLOGY (2020)
Microbiota: a novel regulator of pain
Manon Defaye et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
Mario Matijasic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
From Association to Causality: the Role of the Gut Microbiota and Its Functional Products on Host Metabolism
Ara Koh et al.
MOLECULAR CELL (2020)
Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study
Talia Palacios et al.
NUTRIENTS (2020)
Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy
Binbin Lin et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes
Yayun Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy
Rajagopalaboopathi Jayasudha et al.
PLOS ONE (2020)
Streptozotocin-Induced Diabetes Mellitus in Neonatal Rats: An Insight into its Applications to Induce Diabetic Complications
Mirza Anwar Baig et al.
CURRENT DIABETES REVIEWS (2020)
Probiotic Soy Milk Consumption and Renal Function Among Type 2 Diabetic Patients with Nephropathy: a Randomized Controlled Clinical Trial
Maryam Miraghajani et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2019)
Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial
Shaun Sabico et al.
CLINICAL NUTRITION (2019)
Probiotics: How Effective Are They in the Fight against Obesity?
Kiran Mazloom et al.
NUTRIENTS (2019)
Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut
Xiuli Zeng et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
Mihai Covasa et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Clara Depommier et al.
NATURE MEDICINE (2019)
Change of intestinal microbiota in cerebral ischemic stroke patients
Na Li et al.
BMC MICROBIOLOGY (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice
Amrisha Verma et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
The Effects of Probiotic Honey Consumption on Metabolic Status in Patients with Diabetic Nephropathy: a Randomized, Double-Blind, Controlled Trial
Navid Mazruei Arani et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2019)
Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: A double blind, randomized, placebo controlled study
Ratna Sudha Madempudi et al.
PLOS ONE (2019)
The gut microbiota to the brain axis in the metabolic control
Estelle Grasset et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2019)
Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy
Rosa Fernandes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Biogeography of the human ocular microbiota
Jerome Ozkan et al.
OCULAR SURFACE (2019)
Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial
Leila Khalili et al.
DIABETOLOGY & METABOLIC SYNDROME (2019)
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy
Luiz C. S. P. Rolim et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial
Elham Razmpoosh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial
Nazila Kassaian et al.
ACTA DIABETOLOGICA (2018)
Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes
Arash Haghikia et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice
Eleni Beli et al.
DIABETES (2018)
Recombinant Probiotics Expressing Angiotensin-(1-7) Improves Glucose Metabolism and Diabetes-Induced Renal and Retinal Injury
Qiuhong Li et al.
DIABETES (2018)
Limb- and Person-Level Risk Factors for Lower-Limb Amputation in the Prospective Seattle Diabetic Foot Study
Edward J. Boyko et al.
DIABETES CARE (2018)
Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation
Gard F. T. Svingen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Gut-microbiome-related LCT genotype and 2-year changes in body composition and fat distribution: the POUNDS Lost Trial
Yoriko Heianza et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus
Mehmet Kanbay et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling
Ying Wang et al.
JOURNAL OF CELL BIOLOGY (2018)
Microbial modulation of cardiovascular disease
J. Mark Brown et al.
NATURE REVIEWS MICROBIOLOGY (2018)
The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial
Fariba Raygan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314
Kimbria J. Blake et al.
NATURE COMMUNICATIONS (2018)
The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease
Fariba Raygan et al.
DIABETOLOGY & METABOLIC SYNDROME (2018)
An insight into intestinal mucosal microbiota disruption after stroke
Dragana Stanley et al.
SCIENTIFIC REPORTS (2018)
Dysbiosis signatures of gut microbiota in coronary artery disease
Qi Zhu et al.
PHYSIOLOGICAL GENOMICS (2018)
Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients
Jing Nie et al.
STROKE (2018)
Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
Mathilde Nativel et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease
Mobin Malik et al.
CIRCULATION RESEARCH (2018)
The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial
Ming-Chia Hsieh et al.
SCIENTIFIC REPORTS (2018)
The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial
Sima Mohseni et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial
Nazarii Kobyliak et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2018)
Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease
Andre Fialho et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus
W. H. Wilson Tang et al.
CLINICAL CHEMISTRY (2017)
Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial
Somayyeh Firouzi et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight Type 2 Diabetic Patients with - Coronary Heart Disease
M. Tajabadi-Ebrahimi et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2017)
Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease
Takuo Emoto et al.
HEART AND VESSELS (2017)
Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
Cristiane C. K. Mayerhofer et al.
JOURNAL OF CARDIAC FAILURE (2017)
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data
Evgenia Gourgari et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Bacterial Signaling to the Nervous System through Toxins and Metabolites
Nicole J. Yang et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
The Impact of Probiotic Soy Milk Consumption on Oxidative Stress Among Type 2 Diabetic Kidney Disease Patients: A Randomized Controlled Clinical Trial
Maryam Miraghajani et al.
JOURNAL OF RENAL NUTRITION (2017)
Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naive T2DM patients: a randomized clinical trial
Shaun Sabico et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects
Alireza Soleimani et al.
KIDNEY INTERNATIONAL (2017)
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu et al.
NATURE MEDICINE (2017)
Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing
Li Cui et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
Kazuo Yamashiro et al.
PLOS ONE (2017)
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
Kai-Yu Xu et al.
SCIENTIFIC REPORTS (2017)
Alteration of the gut microbiota in Chinese population with chronic kidney disease
Shuanghong Jiang et al.
SCIENTIFIC REPORTS (2017)
Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?
Evgenia Gourgari et al.
CURRENT DIABETES REPORTS (2017)
The impact of gut microbiota on kidney function and pathogenesis
Fariba Mahmoodpoor et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
Sang-Hak Lee
ENDOCRINOLOGY AND METABOLISM (2017)
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
Fatemeh Mofidi et al.
BRITISH JOURNAL OF NUTRITION (2017)
Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial
Reza Mobini et al.
DIABETES OBESITY & METABOLISM (2017)
An Intestinal Organ Culture System Uncovers a Role for the Nervous System in Microbe-Immune Crosstalk
Nissan Yissachar et al.
CELL (2017)
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease
Alice Sabatino et al.
CURRENT DIABETES REPORTS (2017)
Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study
Livia Bordalo Tonucci et al.
CLINICAL NUTRITION (2017)
Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: a randomized controlled trial
Ameneh Madjd et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
The gut microbiota and host health: a new clinical frontier
Julian R. Marchesi et al.
GUT (2016)
Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target
Ali Ramezani et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice
James M. Dominguez et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes
Adil Mardinoglu et al.
CELL METABOLISM (2016)
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial
Megan Rossi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Defining the normal core microbiome of conjunctival microbial communities
Y. Huang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial
M. Karamali et al.
DIABETES & METABOLISM (2016)
The use of probiotic L. fermentum ME-3 containing Reg'Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study
Tiiu Kullisaar et al.
NUTRITION JOURNAL (2016)
Higher diversity in fungal species discriminates children with type 1 diabetes mellitus from healthy control
Beata Kowalewska et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
Complications of Diabetes 2016
Konstantinos Papatheodorou et al.
JOURNAL OF DIABETES RESEARCH (2016)
Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats
Vy Lam et al.
PLOS ONE (2016)
Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats
Dorothy A. Kieffer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Diabetic Retinopathy: Battling the Global Epidemic
Arup Das
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Epidemiology of Peripheral Artery Disease
Michael H. Criqui et al.
CIRCULATION RESEARCH (2015)
The role of the gut microbiome in the healthy adult status
Valeria D'Argenio et al.
CLINICA CHIMICA ACTA (2015)
Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept
Marie-Christine Simon et al.
DIABETES CARE (2015)
Obesity changes the human gut mycobiome
M. Mar Rodriguez et al.
SCIENTIFIC REPORTS (2015)
Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults
A. T. Bjerg et al.
BENEFICIAL MICROBES (2015)
Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack
Jia Yin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study
Hemalatha Rajkumar et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Ryan Lee et al.
EYE AND VISION (2015)
Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study)
Karen L. Lindsay et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Tannaz Eslamparast et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Visit-to-Visit Variability in Blood Pressure and Kidney and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Nephropathy: A Post Hoc Analysis From the RENAAL Study and the Irbesartan Diabetic Nephropathy Trial
Ciaran J. McMullan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Coronary Artery Disease and Diabetes Mellitus
Doron Aronson et al.
CARDIOLOGY CLINICS (2014)
Effects of synbiotic food consumption on metabolic status of diabetic patients: A double-blind randomized cross-over controlled clinical trial
Zatollah Asemi et al.
CLINICAL NUTRITION (2014)
The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial
K. L. Ivey et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2014)
Effects of a Symbiotic on Gut Microbiota in Mexican Patients With End-Stage Renal Disease
Jose Cruz-Mora et al.
JOURNAL OF RENAL NUTRITION (2014)
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010
Valery L. Feigin et al.
LANCET (2014)
Consumption of Synbiotic Bread Decreases Triacylglycerol and VLDL Levels While Increasing HDL Levels in Serum from Patients with Type-2 Diabetes
Hossein Shakeri et al.
LIPIDS (2014)
Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects
Akihiro Ogawa et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Effect of Probiotic (VSL#3) and Omega-3 on Lipid Profile, Insulin Sensitivity, Inflammatory Markers, and Gut Colonization in Overweight Adults: A Randomized, Controlled Trial
Hemalatha Rajkumar et al.
MEDIATORS OF INFLAMMATION (2014)
Topical application/formulation of probiotics: Will it be a novel treatment approach for diabetic foot ulcer?
M. Sonal Sekhar et al.
MEDICAL HYPOTHESES (2014)
Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction
Nosratola D. Vaziri et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Effect of Multispecies Probiotic Supplements on Metabolic Profiles, hs-CRP, and Oxidative Stress in Patients with Type 2 Diabetes (Publication with Expression of Concern. See JAN, 2023)
Zatollah Asemi et al.
ANNALS OF NUTRITION AND METABOLISM (2013)
Long-Term Complications and Mortality in Young-Onset Diabetes
Maria I. Constantino et al.
DIABETES CARE (2013)
Diabetic Neuropathy
Aaron I. Vinik et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2013)
Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial
Z. Asemi et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2013)
In This Issue: Immunology of the Eye-Inside and Out
Rachel R. Caspi
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients - a randomized double-blind placebo-controlled pilot study
Khaider K. Sharafedtinov et al.
NUTRITION JOURNAL (2013)
Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial
Seung-Pil Jung et al.
KOREAN JOURNAL OF FAMILY MEDICINE (2013)
Evaluation of wound healing activities of kefir products
Hassan Fallah Huseini et al.
BURNS (2012)
The Impact of the Gut Microbiota on Human Health: An Integrative View
Jose C. Clemente et al.
CELL (2012)
Intestinal microbiota determine severity of myocardial infarction in rats
Vy Lam et al.
FASEB JOURNAL (2012)
Probiotics to Adolescents With Obesity: Effects on Inflammation and Metabolic Syndrome
Rikke Juul Gobel et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
Amrisha Verma et al.
MOLECULAR THERAPY (2012)
Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients
Feiqian Wang et al.
NEPHROLOGY (2012)
Probiotic yogurt improves antioxidant status in type 2 diabetic patients
Hanie S. Ejtahed et al.
NUTRITION (2012)
Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: A randomized control trial
Mitchell L. Jones et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2012)
Symptomatic atherosclerosis is associated with an altered gut metagenome
Fredrik H. Karlsson et al.
NATURE COMMUNICATIONS (2012)
The Therapeutic Implications of Renin-Angiotensin System Blockade in Diabetic Retinopathy
V. Swetha E. Jeganathan
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Diabetic Foot
M. Lepantalo et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2011)
Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review
A. K. Sjolie et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Targeted therapies in diabetic nephropathy: an update
Ankur Gupta et al.
JOURNAL OF NEPHROLOGY (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Oxidative stress in early diabetic nephropathy: fueling the fire
Dhruv K. Singh et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Mechanism of diabetic neuropathy: Where are we now and where to go?
Soroku Yagihashi et al.
JOURNAL OF DIABETES INVESTIGATION (2011)
Overview of Newer Agents: Where Treatment Is Going
Ralph A. DeFronzo
AMERICAN JOURNAL OF MEDICINE (2010)
Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
Michael Bader
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects
Anne Sofie Andreasen et al.
BRITISH JOURNAL OF NUTRITION (2010)
Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial
Kirsi Laitinen et al.
BRITISH JOURNAL OF NUTRITION (2009)
Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada
Natarajan Ranganathan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Towards the human intestinal microbiota phylogenetic core
Julien Tap et al.
ENVIRONMENTAL MICROBIOLOGY (2009)
Diabetes Complications and the Renin-Angiotensin System.
Bruce A. Perkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome
Brian V. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol
Leon A. Simons et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2006)
Preventing foot ulcers in patients with diabetes
N Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Diabetic nephropathy: Diagnosis, prevention, and treatment
JL Gross et al.
DIABETES CARE (2005)
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes
R Stevens et al.
DIABETES CARE (2004)
Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis
F Takayama et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers
M Naruszewicz et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2002)
Share Paper
